MAP
CDLX icon

Madison Avenue Partners’s Cardlytics CDLX Stock Holding History

Madison Avenue Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,890
Closed -$4.16M – 13
2020
Q3 		$4.16M Buy
+5,890
New +$4.28M 1.49% 13

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Madison Avenue Partners's CDLX Position: Q4 2020 in Review

Madison Avenue Partners sold out of Cardlytics (CDLX) in Q4 2020, closing a stake of 5,890 shares — an estimated $4.16M sold.

Madison Avenue Partners first reported a position in CDLX in Q3 2020 and held it in 1 quarter. The position peaked at $4.16M in Q3 2020. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.

  • Madison Avenue Partners reported no remaining Cardlytics position as of Q4 2020 after selling out during the quarter.
  • Madison Avenue Partners sold 5,890 Cardlytics shares in Q4 2020, an estimated $4.16M.
  • Madison Avenue Partners first reported a position in Cardlytics in Q3 2020 and held it in 1 quarter.
  • Madison Avenue Partners's Cardlytics position peaked at $4.16M in Q3 2020.
  • 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.

Based on Madison Avenue Partners's 13F filing for Q4 2020, filed 12 Feb 2021.